Free Trial
NASDAQ:MAZE

Maze Therapeutics (MAZE) Stock Price, News & Analysis

Maze Therapeutics logo
$13.14 -0.18 (-1.35%)
As of 04:00 PM Eastern

About Maze Therapeutics Stock (NASDAQ:MAZE)

Key Stats

Today's Range
$12.95
$13.86
50-Day Range
$10.24
$17.78
52-Week Range
$6.71
$19.19
Volume
72,288 shs
Average Volume
202,454 shs
Market Capitalization
$575.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.60
Consensus Rating
Buy

Company Overview

Receive MAZE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MAZE Stock News Headlines

Analysts Set Maze Therapeutics, Inc. (NASDAQ:MAZE) PT at $25.60
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
MAZE Stock Price Quote | Morningstar
See More Headlines

MAZE Stock Analysis - Frequently Asked Questions

Maze Therapeutics' stock was trading at $13.38 at the beginning of the year. Since then, MAZE stock has decreased by 1.8% and is now trading at $13.14.

Maze Therapeutics, Inc. (NASDAQ:MAZE) released its quarterly earnings results on Wednesday, May, 14th. The company reported ($1.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.76) by $0.39.

Maze Therapeutics (MAZE) raised $140 million in an IPO on Friday, January 31st 2025. The company issued 8,750,000 shares at a price of $16.00 per share.

Maze Therapeutics's lock-up period expired on Wednesday, July 30th. Maze Therapeutics had issued 8,750,000 shares in its public offering on January 31st. The total size of the offering was $140,000,000 based on an initial share price of $16.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

Maze Therapeutics' top institutional shareholders include Geode Capital Management LLC (0.53%) and CWM LLC (0.01%).

Shares of MAZE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/14/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MAZE
Previous Symbol
NASDAQ:MAZE
CIK
1842295
Web
N/A
Fax
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

High Price Target
$34.00
Low Price Target
$17.00
Potential Upside/Downside
+90.5%
Consensus Rating
Buy
Rating Score (0-4)
3.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.10
Quick Ratio
16.10

Sales & Book Value

Annual Sales
$167.50 million
Price / Sales
3.51
Cash Flow
$0.14 per share
Price / Cash Flow
93.08
Book Value
($7.11) per share
Price / Book
-1.89

Miscellaneous

Outstanding Shares
43,800,000
Free Float
N/A
Market Cap
$588.67 million
Optionable
N/A
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MAZE) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners